Related Experiment Videos
Conformal radiotherapy for prostate cancer
1Department of Radiation Oncology, Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA 19111, USA. ge_hanks@fccc.edu
Annals of Medicine
|March 11, 2000
Summary
Three-dimensional conformal radiation treatment significantly improves prostate cancer cure rates by delivering higher, effective radiation doses. This advanced technique also reduces complications compared to standard radiation therapy, making it a superior treatment option.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- External beam radiation therapy is a standard treatment for prostate cancer.
- Three-dimensional conformal radiation treatment (3D-CRT) has evolved over the past decade.
- Standard radiation techniques may have limitations in dose delivery and toxicity.
Purpose of the Study:
- To review the impact of 3D-CRT on prostate cancer treatment outcomes.
- To highlight the benefits of conformal techniques in delivering higher radiation doses.
- To compare the efficacy and safety of 3D-CRT with standard radiation methods.
Main Methods:
- Review of 10 years of institutional experience with 1500 prostate cancer patients treated with 3D-CRT.
- Inclusion of data from other institutions and RTOG clinical trials.
- Emphasis on critical technical aspects: patient immobilization, CT-based 3D targeting, and beams-eye-view portals.
Main Results:
- A steep dose-response curve indicates higher radiation doses correlate with significantly improved cure rates (14-35% increase in 5-year cures).
- 3D-CRT protects surrounding normal tissues, resulting in fewer late complications than standard techniques.
- Higher radiation doses (75-80 Gy) are achievable and safe with conformal therapy.
Conclusions:
- Conformal therapy offers superior outcomes for prostate cancer, achieving higher cure rates with reduced complications.
- 3D-CRT represents a significant advancement over standard radiation techniques for prostate cancer.
- Widespread adoption of conformal therapy in radiation oncology practice is recommended worldwide.